The Federal Register

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Type-2 Diabetes Prevention in

Thu, Jun 26 2008 11:00:00 GMT

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

Time and Date: 1 p.m.4 p.m., July 11, 2008 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92463.

Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ``Type2 Diabetes Prevention in [[Page 36329]]
Women with a Recent History of Gestational Diabetes Mellitus, PEP 2008R04.''

Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 4981194.

The Director, Manageme

Agency Information Collection Activities: Proposed Collection; Comment Request

Thu, Jun 26 2008 11:00:00 GMT

Agency Information Collection Activities: Submission for OMB Review; Comment Request

Thu, Jun 26 2008 11:00:00 GMT

Submission for OMB Review; Comment Request

Thu, Jun 26 2008 11:00:00 GMT

Title: Voluntary Surveys of Program Partners to Implements Executive Order 12862

OMB No.: 09800266

Description: Under the provisions of the Federal Paperwork Reduction Act of 1995 (Pub. L. 10413), the Administration for Children and Families (ACF) is requesting clearance for instruments to implement Executive Order 12862 within ACF. The purpose of the data collection is to obtain customer satisfaction information from those entities who are funded to be our partners in the delivery of services to the American public. ACF partners are those entities that receive funding to deliver services or assistance from ACF programs. Examples of partners are state and local governments, territories, service providers, Indian Tribes and Tribal organizations, grantees, researchers, or other intermediaries serving target populations identified by and funded directly or indirectly by ACF. The surveys will obtain information about how well ACF is meeting the needs of our partners in operating the ACF

Office of Refugee Resettlement; Unaccompanied Alien Children Shelter Care Facilities

Thu, Jun 26 2008 11:00:00 GMT

This notice announces that the Administration for Children and Families (ACF), Office of Refugee Resettlement intends to award ten unaccompanied alien shelter care providers in the amount of $2,521,320. This funding will support services through September 30, 2008. Grantee Location Project period Amount Southwest KeyEl Paso............... El Paso, TX............ 06/10/0809/30/08 $390,320 The Children's Village............... New York, NY........... 06/10/0809/30/08 445,000 Florence Crittenton.................. Los Angeles, CA........ 06/10/0809/30/08 336,000 Lutheran Social Services of the South Austin, TX............. 06/10/0809/30/08 600,000 Heartland/ICC........................ Chicago, IL............ 06/10/0809/30/08 325,000 Southwest Indiana Youth Village...... Vincennes, IN.......... 06/10/0809/30/08

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request;

Thu, Jun 26 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting

Thu, Jun 26 2008 11:00:00 GMT

This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.

Name of Committee: Hematology and Pathology Devices Panel of the Medical Devices Advisory Committee.

General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.

Date and Time: The meeting will be held on July 18, 2008, from 8 a.m. to 5 p.m.

Location: Hilton Washington DC North/Gaithersburg, Salons A, B, and C, 620 Perry Pkwy., Gaithersburg, MD.

Contact Person: Louise E. Magruder, Center for Devices and Radiological Health (HFZ440), Food and Drug Administration, 2098 Gaither Rd., Rockville, MD 20850, 2402761248, or FDA Advisory Committee Information Line, 18007418138 (3014430572 in the Washington, DC area), code 3014512515. Please call the Information Line for uptodate information on this meeting. A notice in the Federal Register about last minute modifications tha

Office of Global Health Affairs; Regulation on the Organizational Integrity of Entities Implementing Leadership Act

Thu, Jun 26 2008 11:00:00 GMT

The Office of Global Health Affairs within the U.S. Department of Health and Human Services (HHS) is reopening the period to submit comments on the proposed rule, published in the Federal Register of April 17, 2008. The proposed rule describes the separation that must exist between a recipient of HHS funds to implement HIV/AIDS programs and activities under the United States Leadership Against HIV/AIDS, Tuberculosis and Malaria Act of 2003 (the ``Leadership Act''), Public Law No. 10825 (May 27, 2003), and an affiliate organization that engages in activities that are not consistent with a policy opposing prostitution and sex trafficking, as required under section 301(f) of the Leadership Act.

Agency Information Collection Request. 60-Day Public Comment Request

Thu, Jun 26 2008 11:00:00 GMT

Agency Information Collection Request. 60-Day Public Comment Request

Thu, Jun 26 2008 11:00:00 GMT

Agency Information Collection Request. 60-Day Public Comment Request

Thu, Jun 26 2008 11:00:00 GMT

In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed information collection request for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency's functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, email your request, including your a

Office of Clinical and Preventive Services, Division of Nursing Services Nursing Program, Schools of Nursing

Thu, Jun 26 2008 11:00:00 GMT

Announcement Type: Competitive Continuation and New Grants.

Funding Announcement Number: HHS2008IHSNU0001.

Catalog of Federal Domestic Assistance Numbers(s): 93.970

Key Dates:

Application Deadline Date: August 8, 2008.

Review Date: August 18, 2008.

Award Status Notification: August 22, 2008.

Earliest Anticipated Start Date: September 1, 2008. I. Funding Opportunity Description

The Indian Health Service (IHS), Office of Clinical and Preventive Services, Division of Nursing Services, announces a competitive grant application for existing and new grantees under the Nursing Education Program for American Indians/Alaska Natives (AI/AN5). This program is authorized under section 112 of the Indian Health Care Improvement Act, Public Law 94437 as amended. This program is described at 93.970 in the Catalog of Federal Domestic Assistance (CFDA).

The purpose of the Nursing Program Schools of Nursing is to increase the number of nurses, nurse midwives, nurse anesthetists, a

Proposed Collection; Comment Request; Simulations for Drug Related Science Education

Thu, Jun 26 2008 11:00:00 GMT

Summary: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for the opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA), the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.

Proposed Collection: Title: Simulations for Drug Related Science Education. Type of Information Collection Request: NEW. Need and Use of Information Collection: This is a request for a onetime clearance to evaluate an interactive multimedia module developed by ArchieMD. This evaluation seeks to determine whether the multimedia module ArchieMD: The Science of Drugs (1) Increases students' knowledge in brain and heart biology and the effects drugs have on the body (2) Increases positive attitudes towards science education for high school students (3) Reinforces or instills negative attitudes

Notice of Establishment

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Director, National Institutes of Health (NIH), announces the establishment of the Board of Scientific Counselors, National Institute of Biomedical Imaging and Bioengineering (Committee).

This Committee shall advise the Director, NIH; the Deputy Director for Intramural Research, NIH; the Director, National Institute of Biomedical Imaging and Bioengineering (NIBIB); and the Scientific Director, NIBIB, concerning the intramural research programs through periodic visits to the laboratories to assess the research in progress, the proposed research, and evaluation of the productivity and performance of tenured, tenure track and staff scientists and physicians.

This Committee will consist of eight members, including the Chair, appointed by the Director, NIH, from authorities knowledgeable about biomedical imaging and bioengineering.

Duration of this committee is continuing unless formally determined b

National Center for Complementary & Alternative Medicine; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Tools and Technologies to Assess Manual Therapies.

Date: July 22, 2008.

Time: 11:30 a.m. to 1:30 p.m.

Agenda: To review and evaluate grant applications; National Institutes of Health.

Place: Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Tele

National Center for Complementary & Alternative Medicine; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel; Clinical Science.

Date: July 15, 2008.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications; National Institutes of Health.

Place: Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).

Contact Perso

National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, Review of Clinical Trial Planning Grants.

Date: July 2, 2008.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892. (Telephone C

National Institute of Child Health and Human Development; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Attention Trajectories from 5 to 7 Years: A MultiLevel Psychobiological Study.

Date: July 10, 2008.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 208

National Institute of Child Health and Human Development; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institutes of Child Health and Human Development Special Emphasis Panel; Extramural Associates Research Development Award (EARDA).

Date: July 11, 2008.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.

Cont

National Institute of Child Health and Human Development; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Regulation of Placental Signaling and Function by Maternal Nutrient Availability.

Date: July 24, 2008.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD

National Institute of Dental & Craniofacial Research; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Dental and Craniofacial Research, Special Emphasis Panel Review R13.

Date: July 30, 2008.

Time: 1:30 p.m. to 2:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6706 Democracy Blvd., Bethesda, MD 20892. (Telephone Conference Call)

Contact Person: Mary Kelly, Scientific Revie

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Bariatric Surgery Ancillary Studies.

Date: July 17, 2008.

Time: 3 p.m. to 4 p.m.

[[Page 36341]]

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Tel

National Institute of Environmental Health Sciences; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Environmental Health Sciences, Special Emphasis Panel NIH Pathway to Independence.

Date: July 2324, 2008.

Time: 12 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Sheraton Chapel Hill Hotel, One Europa Drive, Chapel Hill, NC 27517.

Contact Person: Janice B. Allen, PhD, Scientific Review Administ

National Institute of Mental Health; Notice of Closed Meetings

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and
[[Page 36339]]
the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel; Services in NonSpecialty Settings.

Date: June 27, 2008.

Time: 2 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting

Thu, Jun 26 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Training SEP.

Date: July 18, 2008.

Time: 2 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact Person: Sha

Public Consultation on a Proposed Framework for Oversight of Dual Use Life Sciences Research

Thu, Jun 26 2008 11:00:00 GMT

The Federal Government is sponsoring a public consultation to engage the scientific community and research organizations in a discussion of a framework for the oversight of dual use life sciences research proposed by the National Science Advisory Board for Biosecurity (NSABB), which is an advisory committee to the Federal Government. In its report, the NSABB posed a series of questions on which the Board encouraged the Federal Government to solicit public comment. These questions concerned such matters as the clarity of the criteria proposed by the Board for identifying dual use research of concern, institutional oversight responsibilities, who should make determinations regarding dual use research of concern, and how to balance appropriate controls with academic freedom and scientific exchange. This public consultation is an opportunity for members of the scientific community and general public to provide input on these important issues.